InfraReDx, Inc., a Burlington, Massachusetts-based medical device company developing intelligent cardiovascular diagnostic imaging technologies, completed a $21m equity financing.
Investors include Sanderling Ventures and other new and existing backers.
The funds are being used to support the full commercial launch of the LipiScan™ IVUS Coronary Imaging System, a catheter that combines both near-infrared spectroscopy (NIR) and intravascular ultrasound (IVUS) technologies to both visualize and characterize the intracoronary lipid core plaques (LCP) suspected of causing the majority of heart attacks.
FinSMEs
12/10/2010